Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2005
10/13/2005WO2005095406A1 Compositions useful as inhibitors of protein kinases
10/13/2005WO2005095405A2 6-(2,6-dichlorophenyl)-triazolopyrimidines, methods for the production thereof, use thereof for controlling pathogenic fungi, and agents containing the same
10/13/2005WO2005095404A2 6-(2-fluorophenyl)-triazolopyrimidines, method for producing them, their use for controlling parasitic fungi and agents containing the same
10/13/2005WO2005095403A2 Macrocyclic compounds as inhibitors of viral replication
10/13/2005WO2005095384A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
10/13/2005WO2005095357A2 Pyrimidine derivatives and methods of treatment related to the use thereof
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094878A1 Composition having antitumor effect
10/13/2005WO2005094584A1 5,6-cycloalkyl-7-aminotriazolopyrimidines, method for production and use thereof for the prevention of fungal pests and agents comprising the same
10/13/2005WO2005094251A2 M3muscarinic acetylcholine receptor antagonists
10/13/2005WO2005077954A3 Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
10/13/2005WO2005066142A3 Pyrrolopyrimidine and pyrrolotriazine derivatives as crf receptor antagonists
10/13/2005US20050228181 Serotonin receptor antagonists; nervous system disorders, R)-4-(2,3-dihydro-1,4-benzodioxin-5-yl)- beta -methyl-1-piperazineethanol
10/13/2005US20050228029 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050227992 Protein kinase inhibitors
10/13/2005US20050227988 compounds capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases; gliomas, meningomas, cancers, Hodgkin's disease, retinal vascularization; core structure that comprises a benzazocine moiety
10/13/2005US20050227977 Substituted 1,2,5,10-tetrahydropyridazino [4,5-b]quinoline-1,10-dione compounds and methods for the treatment of pain
10/13/2005US20050227963 Antiinflammatory agents
10/13/2005US20050227335 From fluorescent pseudomonad bacterium, antifungal agent, antimicrobial agent
10/13/2005US20050227309 Optically-detectable enzyme substrates and their method of use
10/13/2005US20050226810 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis
10/13/2005DE102004014534A1 Triazolderivate und Verwendung von Triazolderivaten in organischen Leuchtdioden (OLEDs) Triazole derivatives and use of triazole derivatives in organic light emitting diodes (OLEDs)
10/13/2005CA2562126A1 Pyrazine derivatives and pharmaceutical use thereof
10/13/2005CA2558915A1 Pyrimidine derivatives and methods of treatment related to the use thereof
10/13/2005CA2554551A1 Compositions useful as inhibitors of protein kinases
10/12/2005EP1583757A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
10/12/2005EP1583749A1 Oxazole derivatives as inhibitors of cyclooxygenase
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1583534A1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/12/2005EP1370568B1 Chemical compounds
10/12/2005EP1060163B1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/12/2005CN1681830A Novel chemical substance having morphogenetic and growth-accelerating activities
10/12/2005CN1681819A 6, 7-dihydro-5H-pyrazolo[1, 2-a]pyrazol-1-ones which control inflammatory cytokines
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681817A Biologically active compounds
10/12/2005CN1681810A Novel oxazole and thiazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681809A Novel isothiazole and isoxazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681805A Novel imidazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681508A Novel inhibitors of kinases
10/12/2005CN1681502A Novel triazole compounds as transforming growth factors (TGF) inhibitors
10/12/2005CN1680379A 2-pyridinyl-6, 7, 8, 9-tetrahydropyrimido{1, 2-a}pyrimidin-4-one and 7-pyridinyl-1, 3-dihydoimidazo{1, 2-a}pyrimidin-5(1h)one derivatives
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1680377A 4-oxo-4, 6, 7, 8-tetrahydro-pyrrolo[1, 2-a]pyrazine-6-carboxamide compounds
10/12/2005CN1680376A Polymorphs of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5- alpha ]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
10/12/2005CN1680375A Bisphenols monomer with imide structure and its synthesis
10/12/2005CN1680373A Double piperazine quaternary ammonium salt compound with analgetic function
10/12/2005CN1680340A Novel triazolo pyrimidine compounds
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680336A New imidazole derivative, method for producing the same and use of the same
10/12/2005CN1680274A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
10/12/2005CN1679562A Antiviral compounds
10/12/2005CN1222526C Chlorophyll and bacteriochlorophyll esters, and their preparation
10/12/2005CN1222525C Bicyclic imidazo-3-yl-amine derivs. which are substd. on sixth ring
10/12/2005CN1222286C Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor
10/11/2005US6953947 Organic thin film transistor
10/11/2005US6953855 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953787 5HT2C receptor modulators
10/11/2005US6953679 Biosynthesis with enzyme or microorganism, catalyzing hydroxylation reaction, useful as modulators of nuclear hormone receptor, anticarcinogenic agents, immunomodulators, steroid mimic
10/11/2005US6953570 For therapy of tumors
10/06/2005WO2005093007A1 Triazole derivatives and use thereof in organic light-emitting diodes (oleds)
10/06/2005WO2005092894A1 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms
10/06/2005WO2005092864A1 Imidazole compounds for the treatment of neurodegenerative disorders
10/06/2005WO2005092099A1 Hiv integrase inhibitors
10/06/2005WO2005091711A2 Novel condensed pyrimidones
10/06/2005WO2005073235A3 Process for the synthesis of n- [3-(3-cyanopyrazolo [1,5a] pyrimidin-7-yl)-phenyl]-n-ethyl-acetamide
10/06/2005WO2005073234A3 Imidazo[1,2-c]pyrimidinylacetic acid derivatives
10/06/2005WO2005073216A3 Hcv ns-3 serine protease inhibitors
10/06/2005WO2005069894A3 Conformationally constrained smac mimetics and the uses thereof
10/06/2005US20050222412 Antibiotic; bactericides
10/06/2005US20050222236 Viral polymerase inhibitors
10/06/2005US20050222196 Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
10/06/2005US20050222177 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs
10/06/2005US20050222173 Triazolopyrimidines
10/06/2005US20050222172 Active ingredient in treating neurodegenerative disease, Alzheimer's disease caused by abnormal enzyme activity
10/06/2005US20050222171 Organic compounds
10/06/2005US20050222164 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
10/06/2005US20050222159 2,3-dihydropyridazin-3-ones e.g. 3-amino-6-(1-isopropyl-6-oxo-1,6-dihydro-3-pyridazinyl)-5-phenyl-2-pyrazinecarboxamide; adenosine antagonists; depression, dementia, Parkinson's disease, anxiety, pain, hypertension, obesity, gout, bronchial asthma
10/06/2005US20050222155 Inhibitors of akt activity
10/06/2005US20050222153 Tyrosine kinase enzyme inhibitors as growth factor receptors and useful as antiproliferation agents
10/06/2005US20050222152 Enzyme inhibitors for disease treatment with Cathepsin s
10/06/2005US20050222143 Helix mimetics and composition and methods related thereto
10/06/2005US20050222141 N-(2,6-dichlorobenzoyl)-4-[1-methyl-7-(pyrrolidine-1-ylmethyl)-2,4-quinazoline-dione-3-yl]-L-phenylalanine trifluoroacetate; 4 integrin antagonist; antiinflammatory, anticarcinogenic agent, antiallergent; asthma, psoriasis, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation
10/06/2005US20050222140 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance
10/06/2005US20050222134 Crystalline forms of 5, 11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one
10/06/2005US20050222133 Process for preparing pyrrolo[2, 1-c] [1,4] benzodiazepine hybrids
10/06/2005US20050222132 for example, 7-methoxy-8-[n'-(4''-acridonylcarboxyamido)alkyl]-oxy-(11aS)-1,2,3,11a-tetraydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one; antitumor agents
10/06/2005US20050222131 Useful as antitumour agents
10/06/2005US20050222093 Methods for restoring cognitive function following systemic stress
10/06/2005US20050220784 Quinazoline derivatives as medicaments
10/06/2005DE102004013588A1 Verfahren zur Herstellung von Triethylendiamin aus Monoethanolamin A process for preparing triethylenediamine from monoethanolamine
10/06/2005CA2557785A1 Hiv integrase inhibitors
10/05/2005EP1581539A2 Novel tyrosine kinase inhibitors
10/05/2005EP1581535A1 Pyrrolopyridazine derivatives
10/05/2005EP1581534A2 Tumour-inhibiting annellated azepinone derivatives
1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 573